Comparative Study on the Biological Properties of 2',5'-Oligoadenylate Derivatives with Purified Human RNase L Expressed in E. coli.

概要

論文の詳細を見る
An endoribonuclease, RNase L, which is activated in the presence of 2', 5'-linked oligoadenylates, p1-3A(2'p5'A)2, is the terminal factor of the anti-viral action of interferon. Activation of RNase L results in inhibition of viral proliferation along with induction of apoptosis. Attempts to acquire more effective activators, 2-5A derivatives, have been made for the development of antiviral or anticancer agents. However, the ability of 2-5A derivatives to activate RNase L could not simply be compared due to the diversity of the assay methods used. We have now developed a facile method for assaying the activity of RNase L involving the use of non-fusion RNase L expressed in Escherichia coli and yeast 5S ribosomal RNA as a substrate. Using this method, several 2-5A derivative species have been revaluated. The results suggest that 2-5A molecules modified at the 8-position of the third (from the 5' terminus) adenine ring cause effective dimerization of RNase L and thus increase the ability of RNase L activation.
社団法人日本生化学会の論文